Gut-friendly psychobiotics could brighten moods and fight depression

FHS
April 8, 2024
4:37 am

Review uncovers that psychobiotics may offer supportive treatment for depression by restoring gut microbiome balance and positively influencing the microbiome-gut-brain axis, which is crucial for mental health and well-being.

New research may pave the way for treatment of vaginal yeast infections

New research could one day pave the way for the treatment of vaginal yeast infections, by shedding new light on how microbes in the body

December 7, 2023

Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing

Nvelop Therapeutics launched Tuesday with $100 million in seed funding to advance research from the gene editing pioneers David Liu and Keith Joung, as they

April 10, 2024

Novo nabs over a third of diabetes market, a year ahead of schedule

Novo Nordisk’s GLP-1 drugs may have been the center of attention during its first-quarter earnings call, but the company’s broader diabetes portfolio beat its target

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.